- Home
- / Flynn Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Flynn Pharma financials data including stock price, CreditSafe score, and income statement.
Revenue
£51.6 M
FY, 2016
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
| Revenue | 54.1M | 49.9M | 51.6M |
| Revenue growth, % | -7.7% | 3.5% | |
| Cost of goods sold | 31.7M | 27.7M | 28.1M |
| Gross profit | 22.4M | 22.2M | 23.6M |
| Gross profit margin, % | 41.4% | 44.5% | 45.6% |